+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Tu1904 Interval Cancer After Patients Undergoing Immunochemical Fecal Occult Blood (Fit) or Guaiac Fecal Occult Test (gFobt) in a Population Based Study: Fit Is Protective for up to 3 Years



Tu1904 Interval Cancer After Patients Undergoing Immunochemical Fecal Occult Blood (Fit) or Guaiac Fecal Occult Test (gFobt) in a Population Based Study: Fit Is Protective for up to 3 Years



Gastroenterology 144(5): S-877




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067072040

Download citation: RISBibTeXText

DOI: 10.1016/s0016-5085(13)63260-6


Related references

Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients. Anticancer Research 39(1): 261-269, 2019

T2023 Randomized Trial Comparing the Test Characteristics of Immunochemical Fecal Occult Blood Test At Different Cut-Off Levels to Guaiac-Based Fecal Occult Blood Test. Gastroenterology 136(5): A-622, 2009

A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study. International Journal of Cancer 128(10): 2415-2424, 2011

Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Canadian Journal of Gastroenterology 26(3): 131-147, 2012

Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 109(9): 1925-6; Author Reply 1926, 2007

Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 107(9): 2152-2159, 2006

Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting. Clinical Gastroenterology and Hepatology 15(8): 1265-1270.E1, 2017

Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial. Preventive Medicine 50(5-6): 297-299, 2010

Detection of fecal occult blood in hospitalized patients Comparative evaluation of an immunochemical and a Guaiac test. Gastroenterology 110(4 Suppl. ): A512, 1996

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135(1): 82-90, 2008

Cost-effectiveness of colorectal cancer screening with an immunochemical fecal occult blood test versus guaiac FOBT. American Journal of Gastroenterology 98(9 Suppl.): S221-S222, 2003

Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: a meta-analysis. Journal of Digestive Diseases 11(3): 148-160, 2010

Survival benefit for patients with colorectal cancer detected by population-based screening program using an immunochemical fecal occult blood test. International Journal of Oncology 9(4): 685-691, 1996

Surveillance Colonoscopies in an Organized Colorectal Cancer Screening Program With Guaiac Fecal Occult Blood Test: A Population-Based Cohort Study. Gastroenterology 146(5): S-32, 2014

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening. Plos one 12(3): E0172864, 2017